Jennifer Bath
Chief Executive Officer at IMMUNOPRECISE ANTIBODIES LTD.
Net worth: 378 203 $ as of 2024-03-30
Profile
Jennifer L.
Bath is the founder of Concordia College Global Vaccine Institute, which was founded in 2009.
She served as the Executive Director from 2009 to 2015.
Dr. Bath is currently the President, Chief Executive Officer & Director at ImmunoPrecise Antibodies Ltd.
since 2018.
Previously, she worked as the Global Director-Client Relations at Aldevron LLC from 2015 to 2018 and as an Associate Professor at Concordia University from 2005 to 2015.
Dr. Bath holds a doctorate degree from North Dakota State University and an undergraduate degree from the University of Kansas.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-26 | 248,818 ( 0.95% ) | 378 203 $ | 2024-03-30 |
Jennifer Bath active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNOPRECISE ANTIBODIES LTD. | Chief Executive Officer | 2018-02-20 |
Former positions of Jennifer Bath
| Companies | Position | End |
|---|---|---|
Aldevron LLC
 Aldevron LLC BiotechnologyHealth Technology Aldevron LLC engages in the provision of biotechnology services. It offers plasmid DNA, antibodies, and proteins. The company was founded by Michael Chambers and John Ballantyne in 1998 and is headquartered in Fargo, ND. | Corporate Officer/Principal | 2018-01-31 |
| Concordia University | Corporate Officer/Principal | 2015-07-31 |
| Concordia College Global Vaccine Institute | Founder | 2015-07-31 |
Training of Jennifer Bath
| North Dakota State University | Doctorate Degree |
| University of Kansas | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| IMMUNOPRECISE ANTIBODIES LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Aldevron LLC
Aldevron LLC BiotechnologyHealth Technology Aldevron LLC engages in the provision of biotechnology services. It offers plasmid DNA, antibodies, and proteins. The company was founded by Michael Chambers and John Ballantyne in 1998 and is headquartered in Fargo, ND. | Health Technology |
- Stock Market
- Insiders
- Jennifer Bath
